nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxychloroquine—Abnormal pigmentation—Cyclosporine—focal segmental glomerulosclerosis	0.214	0.214	CcSEcCtD
Hydroxychloroquine—Atrophy—Cyclosporine—focal segmental glomerulosclerosis	0.0619	0.0619	CcSEcCtD
Hydroxychloroquine—Pigmentation disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0605	0.0605	CcSEcCtD
Hydroxychloroquine—Bullous eruption—Cyclosporine—focal segmental glomerulosclerosis	0.0511	0.0511	CcSEcCtD
Hydroxychloroquine—Psoriasis—Cyclosporine—focal segmental glomerulosclerosis	0.0321	0.0321	CcSEcCtD
Hydroxychloroquine—Myopathy—Cyclosporine—focal segmental glomerulosclerosis	0.0288	0.0288	CcSEcCtD
Hydroxychloroquine—Cardiovascular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.023	0.023	CcSEcCtD
Hydroxychloroquine—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.0212	0.0212	CcSEcCtD
Hydroxychloroquine—Hepatocellular injury—Cyclosporine—focal segmental glomerulosclerosis	0.0202	0.0202	CcSEcCtD
Hydroxychloroquine—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.0195	0.0195	CcSEcCtD
Hydroxychloroquine—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.0168	0.0168	CcSEcCtD
Hydroxychloroquine—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.0164	0.0164	CcSEcCtD
Hydroxychloroquine—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.0155	0.0155	CcSEcCtD
Hydroxychloroquine—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.0153	0.0153	CcSEcCtD
Hydroxychloroquine—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.015	0.015	CcSEcCtD
Hydroxychloroquine—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.015	0.015	CcSEcCtD
Hydroxychloroquine—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.0144	0.0144	CcSEcCtD
Hydroxychloroquine—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.0139	0.0139	CcSEcCtD
Hydroxychloroquine—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.0134	0.0134	CcSEcCtD
Hydroxychloroquine—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.0129	0.0129	CcSEcCtD
Hydroxychloroquine—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.0125	0.0125	CcSEcCtD
Hydroxychloroquine—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.0115	0.0115	CcSEcCtD
Hydroxychloroquine—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.0113	0.0113	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.0102	0.0102	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.0101	0.0101	CcSEcCtD
Hydroxychloroquine—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00977	0.00977	CcSEcCtD
Hydroxychloroquine—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00945	0.00945	CcSEcCtD
Hydroxychloroquine—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00896	0.00896	CcSEcCtD
Hydroxychloroquine—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00888	0.00888	CcSEcCtD
Hydroxychloroquine—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00882	0.00882	CcSEcCtD
Hydroxychloroquine—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00866	0.00866	CcSEcCtD
Hydroxychloroquine—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00857	0.00857	CcSEcCtD
Hydroxychloroquine—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00831	0.00831	CcSEcCtD
Hydroxychloroquine—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00815	0.00815	CcSEcCtD
Hydroxychloroquine—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00811	0.00811	CcSEcCtD
Hydroxychloroquine—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00806	0.00806	CcSEcCtD
Hydroxychloroquine—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00793	0.00793	CcSEcCtD
Hydroxychloroquine—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.0079	0.0079	CcSEcCtD
Hydroxychloroquine—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00764	0.00764	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00746	0.00746	CcSEcCtD
Hydroxychloroquine—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.0072	0.0072	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00706	0.00706	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00705	0.00705	CcSEcCtD
Hydroxychloroquine—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00699	0.00699	CcSEcCtD
Hydroxychloroquine—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00686	0.00686	CcSEcCtD
Hydroxychloroquine—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.0064	0.0064	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00626	0.00626	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00622	0.00622	CcSEcCtD
Hydroxychloroquine—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00621	0.00621	CcSEcCtD
Hydroxychloroquine—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00616	0.00616	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00589	0.00589	CcSEcCtD
Hydroxychloroquine—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00572	0.00572	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00569	0.00569	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00569	0.00569	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.0053	0.0053	CcSEcCtD
Hydroxychloroquine—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00517	0.00517	CcSEcCtD
Hydroxychloroquine—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00509	0.00509	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00493	0.00493	CcSEcCtD
Hydroxychloroquine—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00476	0.00476	CcSEcCtD
Hydroxychloroquine—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00458	0.00458	CcSEcCtD
Hydroxychloroquine—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00454	0.00454	CcSEcCtD
Hydroxychloroquine—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00454	0.00454	CcSEcCtD
Hydroxychloroquine—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00451	0.00451	CcSEcCtD
Hydroxychloroquine—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00428	0.00428	CcSEcCtD
